Characterization of the polarized endothelial secretom by Wei, Haoche et al.
                          Wei, H., Sundararaman, A., Dickson, E. J., Rennie-Campbell, L., Cross, E.,
Heesom, K. J., & Mellor, H. (2019). Characterization of the polarized
endothelial secretom. FASEB Journal. https://doi.org/10.1096/fj.201900262R
Early version, also known as pre-print
Link to published version (if available):
10.1096/fj.201900262R
Link to publication record in Explore Bristol Research
PDF-document
This is the submitted manuscript (SM). The final published version is available online via [insert publisher name]
at
Federation of American Society of Experimental Biology (https://www.fasebj.org/doi/10.1096/fj.201900262R.
Please refer to any applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
 1
 
 
Characterization of the polarized endothelial secretome 
 
Haoche Wei*,†, Ananthalakshmy Sundararaman†, Emily Dickson†, Lewis Rennie-Campbell†, 
Eloise Cross†, Kate J. Heesom† and Harry Mellor†,1 
 
*Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, Centre for 
Growth, Metabolism and Aging, College of Life Sciences, Sichuan University, Chengdu, China; 
and †School of Biochemistry, Biomedical Sciences Building, Faculty of Life Sciences, 
University of Bristol, Bristol BS8 1TD. 
 
 
 
1Corresponding author: 
 
Professor Harry Mellor 
 
School of Biochemistry, 
Biomedical Sciences Building, 
University of Bristol, 
Bristol BS8 1TD, UK 
 
email: h.mellor@bristol.ac.uk 
tel:  +44 (0)117 3312174 
fax: +44 (0)117 3312168 
 
 
 
 
Running title:   Characterization of the polarized endothelial secretome 
 2
 
 3
Abbreviations:  Ang2; angiopoietin-2, EC; endothelial cell, ECM; extracellular matrix, EV; 
extracellular vesicle, FGF; fibroblast growth factor, HUVEC; human umbilical cord ECs, IGF-1; 
insulin-like growth factor-1, Tsp1; thrombospondin-1. 
 
 
 
 
  
 4
ABSTRACT 
Endothelial cells form an active barrier between the circulation and the body.  In addition to 
controlling transport of molecules between these two compartments, the endothelium is a major 
secretory organ – releasing proteins both into the circulation and into the vascular matrix.  While 
it is clearly important that proteins are correctly sorted into these two spaces, we currently know 
little of the polarization of this secretion or how it is controlled.  Here we present an optimized 
system for the analysis of polarized secretion and show that it allows the derivation of deep, 
robust proteomes from small numbers of primary endothelial cells.  We present the first 
endothelial apical and basolateral secreted proteomes, demonstrating that endothelial cells 
polarize the secretion of extracellular vesicle cargoes to the apical surface.  Conversely, we find 
that protein secretion at the basolateral surface is focused on components of the extracellular 
matrix.  Finally, we examine the role of liprin-α1 in secretion towards the basolateral 
compartment and identify a subset of extracellular matrix components that share this route with 
fibronectin. 
 
Keywords:  Endothelial cell, secretion, extracellular matrix, polarization, intracellular traffic. 
 
INTRODUCTION 
Endothelial cells (ECs) in a healthy endothelium form a highly polarized monolayer, with their 
apical (luminal) surface facing the blood space, and their basolateral (abluminal) surface facing 
the vascular matrix (1).  ECs are secretory cells, and protein secretion is a critical part of EC 
function (2).  ECs must secrete extracellular matrix (ECM) components to form the basal lamina, 
the specialized layer that underlies ECs in stable vessels (3).  ECs must also secrete a range of 
paracrine, autocrine, and endocrine factors that mediate multiple aspects of EC function. These 
molecules affect vascular tone, proliferation of ECs and vascular smooth muscle cells, EC-
leukocyte interactions, platelet adhesion, coagulation, inflammation, and permeability (2, 4).   
 
To carry out these specialized secretory functions, ECs contain specialized adaptions to the 
generalized intracellular trafficking pathways.  ECs are unique in producing Weibel−Palade 
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bodies; a specialized secretory organelle which mediates the controlled secretion of von 
Willebrand Factor during thrombosis and hemostasis (5).  They also have abundant caveolae; 
specialized endocytic carriers that mediate transcytosis of albumin and associated molecules 
across the endothelial layer (6).   There is evidence that different EC subtypes have different 
secretory capacities, depending on their location in the vasculature (2).  Additionally, recent 
work has shown that ECs from different tissue beds secrete tissue-specific combinations of 
angiocrine factors to mediate tissue-specific paracrine regulation of tissue homeostasis and 
regeneration (7).   
 
Despite the obvious importance of proteins secretion to EC function, we are only beginning to 
understand the EC proteome and the mechanisms controlling EC secretion.  The first 
comprehensive proteomic analysis of secreted EC proteins was carried out with human umbilical 
vein ECs (HUVEC); the most widely studied EC subtype.  This identified 374 secreted proteins, 
ranging from components of the ECM through to angiocrine factors (8).  Subsequent proteomic 
studies have examined how HUVEC protein secretion changes in response to proinflammatory 
stimuli (9, 10), proangiogenic stimuli (10, 11) and to shear stress (12).  Taken together, these 
studies are beginning to uncover how dynamic regulation matches the EC secretome to EC 
function. 
 
To date, all proteomic analysis of EC secretion has been on the total secreted proteome, and we 
know little of the polarity of secretion and the differences between the proteins secreted into the 
blood and tissue spaces.  Early studies showed that ECs secrete more protein to the basolateral 
space than the apical space (14).  The secretion of cellular fibronectin, an important component 
of the vascular matrix, was shown to be polarized to the basolateral surface (13, 14).  The growth 
factor PDGFβ is also secreted to the basolateral space, allowing for the regulation of mural cell 
recruitment and proliferation (15).  Similarly, the secretion of endothelin-1, a potent regulator of 
vascular tone, is also highly polarized to the basolateral surface.  Endothelin-1 acts on vascular 
smooth muscle cells of the vessel wall to drive vasoconstriction and this polarized secretion 
allows localized targeting of these cells (16).  Conversely, release of the proinflammatory 
chemokines IL-6 and TNF- α is highly polarized to the apical space, allowing these mediators to 
reach more distant tissues via the blood (17).  In some cases, ECs are able to control the polarity 
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of secretion dependent on context; releasing von Willebrand Factor as a low molecular weight 
form constitutively from their basolateral surface, but as a multimerized form from the apical 
surface on activation.  The basolaterally-secreted von Willebrand Factor forms a reservoir of 
collagen-bound subendothelial protein, whereas the apically-secreted multimerized factor 
promotes platelet binding and thrombosis (18).  The ability to control the routing of von 
Willebrand Factor in this way allows for the proper control of thrombosis and hemostasis. 
 
Clearly, it is critical that ECs are able to direct proteins to the appropriate cell surface; however, 
we currently know little of how this is regulated, or even which proteins are secreted into the 
vascular matrix and which to the circulation.  Here we present the first proteomic analysis of 
polarized secretion in ECs, defining the apical and basolateral proteomes.  We show that ECs 
polarize secretion of vascular matrix components to the basolateral surface, including not only 
the matrix proteins themselves, but also the wide range of protein factors responsible for matrix 
remodeling.  In contrast, we show the apical EC proteome is primarily composed of proteins 
secreted through the extracellular vesicle pathway.  Finally, we show that this methodology is 
well-suited to the investigation of EC secretion mechanisms by identifying a subset of vascular 
matrix proteins whose polarized secretion is controlled by the cytoskeletal linker protein liprin-
α1. 
 
MATERIALS AND METHODS 
Reagents and antibodies 
Unless stated, all reagents were from Sigma-Aldrich (Dorset, UK).  A mouse monoclonal 
antibody to VE-cadherin (clone 55-7H1) was from BD Biosciences (Berkshire, UK); a rabbit 
polyclonal antibody to ZO-1 (#61-7300) was from ThermoFisher Scientific (Loughborough, 
UK); a rabbit polyclonal antibody to liprin-α1 (#14175) was from Proteintech (Manchester, UK).    
Alexa Fluor 488- and 594-conjugated secondary antibodies were from ThermoFisher Scientific. 
Cell culture 
HUVECs pooled from multiple donors were obtained from Lonza (Basel, Switzerland) and 
cultured in EGM-2 medium (Lonza).  For polarized secretion assays, HUVEC (2 x 105/ml) were 
plated in Transwell tissue culture inserts with 0.4μm pore size (Millipore; Hertfordshire, UK).  
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Cells were cultured for 24h in EGM-2 until they formed a continuous monolayer.  The cells were 
then washed, and the medium replaced with HIFA2 medium.  To make HIFA2 medium, EGM-2 
was prepared without the provided FBS, FGF-2, IGF-1, EGF and VEGF supplements.  This was 
then supplemented with 10ng/ml recombinant human FGF-2 and 20ng/ml recombinant IGF-1 
LR3 (R&D Systems, Oxford, UK) to make HIFA2.  Cells were allowed to condition the medium 
for a further 48h before the medium was collected for analysis.   
Permeability measurements 
HUVEC were cultured in Transwell inserts for 24h, as described above.  FITC-dextran (40kDa) 
was added to the top chamber at a final concentration of 1μg/ml.  After a further 24h, medium 
was collected from the bottom chamber and fluorescence measured in a fluorimeter.  
Permeability of the monolayers to protein was assayed by following the transport of BSA.  Cells 
were cultured in Transwell inserts as described and then fatty-acid free BSA was added to either 
the top, bottom or both chambers at a final concentration of 0.1μg/ml.  After a further 24h, 
samples of medium were removed and BSA was quantified by densitometry of Coomassie Blue 
stained SDS-PAGE gels.  
Immunofluorescence microscopy 
The preparation of cells for immunofluorescence microscopy was carried out as previously 
described (19).  Briefly, cells were fixed in 4% paraformaldehyde in PBS for 15min.  The cells 
were then permeabilized with 0.2% Triton X-100 in PBS for 5min.  Cells were then treated with 
0.1% freshly-prepared sodium borohydride in PBS for 5min to quench autofluorescence.  The 
cells were washed three times in PBS between each step.  The fixed cells were incubated with 
primary antibodies for 1h in PBS, followed by incubation in secondary antibodies for 45min.  
Cells were washed three times in PBS between each step.  The cells were then incubated with 
300nM DAPI for 10min and mounted under Mowiol containing 2.5% (w/v) DABCO as an 
antifade agent.  Confocal microscopy was performed using a Leica SP5 AOBS confocal laser-
scanning microscope with an attached Leica DM I6000 inverted microscope. Confocal sections 
were taken across the z-plane and processed to form a 2D projection representing the full depth 
of the cells. 
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Proteomic analysis 
Conditioned medium was taken from the top and bottom chambers of the Transwell inserts.  The 
two chambers have different volumes, and the apical-derived medium was adjusted to the 
volume of the basolateral-derived medium with HIFA2.  The two equal volumes (1.3ml) of 
medium were then concentrated to 20μl using Amicon Ultracel microconcentrators (3kDa cut-
off; Millipore, Hertfordshire, UK).  Samples were digested with trypsin, labelled with Tandem 
Mass Tag (TMT) six plex reagents according to the manufacturer’s protocol (ThermoFisher 
Scientific) and the labelled samples pooled. This pooled sample was then evaporated to dryness, 
resuspended in 5% formic acid and desalted using a SepPak cartridge according to the 
manufacturer’s instructions (Waters, Massachusetts, USA).  Eluate from the SepPak cartridge 
was again evaporated to dryness and resuspended in 1% formic acid prior to analysis by nano-
LC MSMS using an Orbitrap Fusion Tribrid Mass Spectrometer, as described previously (20). 
The raw data files were processed and quantified using Proteome Discoverer software v2.1 
(ThermoFisher Scientific) and searched against the UniProt Human database (140,000 entries) 
using the SEQUEST algorithm. Peptide precursor mass tolerance was set at 10 ppm, and MS/MS 
tolerance was set at 0.6 Da. Search criteria included the oxidation of methionine (+15.9949) as a 
variable modification and carbamidomethylation of cysteine (+57.0214) and the addition of the 
TMT mass tag (+229.163) to peptide N‐termini and lysine as fixed modifications. Searches were 
performed with full tryptic digestion and a maximum of two missed cleavage events were 
allowed. The reverse database search option was enabled, and all data were filtered to satisfy 
false discovery rate (FDR) of 5%. 
 
siRNA transfection 
Three siRNA oligonucleotide duplexes targeting liprin-α1 were synthesized by Origene 
Technologies (Herford, Germany): LP01; 5’-AGUUUAGACCAAAGGACAUUCGUGG-3’, 
LP02; 5’-GCAUGACCUCAAUGAUAAACUUGAA-3’, LP03; 5’-
CCAAGGUACAAACUCUUAAUGAGCA-3’.  A control siRNA duplex (#SR30004) was also 
from Origene.  Transfection of HUVEC with siRNAs was performed using Genefector 
transfection reagent (Venn Nova Inc, Florida, US), according to the manufacturer’s instructions 
and with a 3h incubation period.  Cells were transfected 48h before the termination of 
experiments. 
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ELISA 
Concentrations of thrombospondin-1, angiopoetin-2 and fibronectin were quantified in 
conditioned medium using ELISA kits, used according to the manufacturers’ instructions (R&D 
Systems). 
 
SDS-PAGE and western blotting 
Proteins were analyzed by SDS-PAGE on 10% polyacrylamide gels.  Proteins were transferred 
to polyvinylidene fluoride membrane for immunoblotting. 
 
Statistical analysis 
Analysis of differences between multiple samples was made using one-way ANOVA with 
Tukey’s post hoc test. 
 
 
RESULTS 
Optimization of a polarized endothelial monolayer 
We chose HUVEC for our studies; the most widely-used EC subtype, and the cell type used for 
previous proteomic analyses of total secretion (8-11).  To separate the apical and basolateral 
compartments, we cultured cells in Transwell tissue culture inserts with a 0.4μm pore size.  
HUVEC monolayers are known to have a relatively high permeability, and we wanted to 
maximize their barrier function to ensure that secreted proteins could not leak between cells, 
normalizing their distribution.  Commercial endothelial growth medium is optimized for cell 
proliferation, and many of the components that promote proliferation (serum and growth factors) 
also promote junctional instability.  To optimize the barrier properties of the HUVEC, we 
measured the contribution of each of the media supplements.  We used the transport of FITC-
dextran across the monolayer as a measure of permeability.  Removal of serum from the medium 
significantly improved the barrier function (Fig. 1A).  We examined the effects of removing each 
of the other media supplements in a serum-free background.  Removal of hydrocortisone, FGF-2 
or IGF-1 significantly disrupted barrier function, whereas the removal of other components had 
little effect (Fig. 1A).  We also examined the effect of addition of forskolin, a small molecule 
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that raises cellular cAMP and stabilizes EC junctions (21).  Forskolin treatment gave no further 
improvement over the removal of serum (Fig. 1A).   
 
We formulated an optimized serum-free medium comprising EGM-2 base medium supplemented 
with hydrocortisone, IGF-1, FGF-2 and ascorbate (HIFA).  While ascorbate was not required for 
optimal barrier function, its presence is important for normal collagen processing.  In preparation 
for proteomic analysis, we cultured EC monolayers on Transwell inserts in HIFA for 48h and 
then concentrated the medium from the apical and basolateral chambers.  We analyzed the 
protein content of this medium by SDS-PAGE and saw a strong band at approximately 67 kDa, 
consistent with albumin contamination (Fig. 1B).   The same band was present in concentrated 
HIFA medium that had not been exposed to cells, suggesting that this contamination derived 
from the media supplements (Fig. 1B).  Further analysis showed that the FGF-2 and IGF-1 
supplements provided with the medium were the source of this band, and of several other 
contaminating proteins (Fig. 1B).  We replaced these with purified recombinant growth factors, 
to produce a medium with negligible protein content (Fig. 1B).  This formulation was termed 
HIFA2, and a full description of the formulation is given in the Methods section.  HIFA2 gave a 
42% improvement to barrier function compared to the original EGM-2 (Fig. 1A).  HUVEC 
cultured in EGM-2 displayed the characteristic ‘zipper’ morphology of unstable cell-cell 
junctions, whereas cells cultured in HIFA2 had more linear, continuous junctions (Fig. 1C).  To 
determine whether these junctions were stable enough to maintain an asymmetric distribution of 
proteins across the barrier, we incubated cells with exogenous albumin.   Addition of albumin to 
either side of the EC monolayer resulted in transport of only 20% of the protein tracer across the 
barrier over a 24h period (Fig. 1D).  ECs facilitate movement of albumin across the endothelium 
via transcytosis (22), which will contribute to some of this transport.  We concluded that the 
barrier function of HUVEC cultured in HIFA2 was sufficient for proteomic analysis of polarized 
secretion. 
 
Proteomic analysis of polarized endothelial cell secretion 
Confluent monolayers of HUVEC were transferred to HIFA2 and allowed to condition the 
medium for 48h.  The medium was then collected from the apical and basolateral chambers and 
concentrated by microfiltration.  Tryptic peptides from the samples were subjected to tandem 
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mass tagging; an isobaric labelling strategy that allows for relative quantitative proteomics (23).  
Data were collected from three independent experiments.  In total, 1552 proteins were identified, 
of which 382 proteins were detected in all three experiments Fig. 2A.   The full dataset is 
presented in Supplemental Table S1A.  Table 1 shows the 5 proteins with the most asymmetric 
secretion to the apical and basolateral compartments, respectively.  Cursory examination of the 
data showed that the two proteomes are very different.  Proteins secreted from the basolateral 
surface of ECs were largely conventionally secreted proteins and were enriched in components 
of the extracellular matrix.  Proteins secreted from the apical surface were enriched in 
components of extracellular vesicles.  In conventional protein secretion, recognition of a signal 
peptide at the N-terminus of the peptide allows for its targeting to the endoplasmic reticulum for 
entry into the secretory pathway.  In contrast, secretion via extracellular vesicles involves the 
packaging of cytosolic proteins into membrane wrappers which are then shed from the cell (24).  
In endothelial cells, these extracellular vesicles play important roles in long-range intercellular 
signaling in the vasculature (25, 26).  Fig. 2B shows a plot of the 840 proteins that were detected 
in at least two independent experiments.  Secretion of the majority of proteins (90%) was 
polarized towards the apical surface.  We analyzed our secreted proteome to identify 
conventional soluble secreted proteins, using the VerSeDa database (27).  Fig. 2C shows the 
relative distribution between the apical and basolateral compartments of proteins with a 
conventional signal peptide and no predicted transmembrane regions.  The majority were either 
polarized towards the basolateral surface or showed no overall polarization.  We also 
interrogated the Matrisome Project database (28) to identify components of the extracellular 
matrix.  ECM proteins showed a similar distribution to the pool of soluble secreted proteins (Fig. 
2C), and 55% of the predicted conventionally secreted EC proteins were also identified in the 
ECM database.  For comparison, we determined the relative distribution of protein makers of 
extracellular vesicles by interrogating the EVpedia database (29).  Fig. 2C shows the relative 
distribution proteins matching to the top 500 human extracellular vesicle (EV) proteins.  
Secretion of EV proteins was highly polarized to the apical surface, with 97% of EV proteins 
showing apical polarization.   
 
To validate the proteomic analysis, we selected representative proteins with a clear polarity to 
their secretion.   Thrombospondin-1 (Tsp1) is a component of the vascular matrix that plays 
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important roles in organization of the ECM and in inhibiting angiogenesis (30).  In keeping with 
this, our proteomic analysis showed that 60% of Tsp1 was secreted to the basolateral 
compartment.  Angiopoietin-2 (Ang2) is a pro-angiogenic factor whose circulating levels are 
elevated in pathological angiogenesis and in inflammation and sepsis (31).  Our proteomic 
analysis showed that 64% of Ang2 was secreted to the apical compartment.  The relative ratio of 
each protein between the apical and basolateral compartments was determined by ELISA (Fig. 
2D).  In each case, the ratio determined from the actual concentrations is in good agreement with 
the ratio estimated by the TMT-based proteomic analysis. 
 
We conclude that there are two major pathways of secretion in ECs, with the conventional 
secretory pathway delivering ECM components to the vascular matrix and the EV pathway 
producing signaling intermediates that are released from the apical surface for propagation of 
long-range signals through the circulation. 
 
Liprin-α1 controls sorting of a subset of ECM proteins to the basolateral surface 
Analysis of the proteomic data demonstrated that our optimized TMT-based protocol was 
capable of generating robust data from small samples of ECs.  Currently little is known of the 
regulation of EC secretion under physiological and pathological conditions and our protocol has 
the potential to allow for relatively straightforward analysis of perturbations to polarized EC 
secretion.  To explore this, we examined the effects of disrupting one specific aspect of EC 
secretion.  While the mechanisms of polarized secretion in ECs are poorly understood, recent 
studies have shown that liprin-α1/PPFAI1 controls the delivery of fibronectin to the basolateral 
face of ECs (32).   Fibronectin is the best characterized EC protein in terms of polarized 
secretion and is delivered mainly to the basolateral surface in resting ECs  (13, 14).  We used 
siRNA mediated silencing to deplete liprin-α1 from ECs, selecting two oligonucleotide duplexes 
that gave effective suppression of expression (Fig. 3A).  We then tested whether silencing of 
liprin-α1 affected EC permeability – which would potentially confound the assay by allowing 
secreted proteins to leak across the EC monolayer.  Neither of the siRNAs significantly affected 
permeability (Fig. 3B).  To confirm the effect of liprin-α1 on fibronectin secretion, we measured 
the concentration of fibronectin in the apical and basolateral compartments by ELISA.  As 
previously reported, fibronectin was secreted predominantly to the basolateral surface (Fig. 3C).  
 13
Interestingly, silencing of liprin-α1 had no effect on the apical secretion of fibronectin, but 
significantly inhibited its delivery to the basolateral compartment (Fig. 3C).  We then performed 
a full proteomic analysis of secretion from ECs silenced for liprin-α1 to identify other proteins 
that might also depend on liprin-α1 for their correct secretion.  The full dataset is presented in 
Supplemental Table S1B.  The vast majority of proteins were unaffected by liprin-α1 depletion; 
however, a subset of proteins showed significant disruption to their normal polarity of secretion 
(Fig. 3D).  We were interested in proteins that were normally secreted to the basolateral surface, 
but which then shifted towards apical secretion on depletion of liprin-α1 – such proteins 
potentially share the same mechanism of polarized secretion as fibronectin.  Table 2 shows the 
four most shifted proteins, with fibronectin as a comparison.  All are conventionally secreted 
proteins, and all showed a more dramatic reduction of basolateral polarization than fibronectin 
itself.  Interestingly, three of these proteins are ECM components that play important roles in the 
regulation and remodeling of the vascular matrix.  The secreted form of dystroglycan-1 binds 
laminin, agrin and perlecan to promote organization of the basement lamina (33).  Lysyl oxidase 
controls the maturation of the vascular matrix and binds directly to fibronectin.  Reduced matrix 
deposition of lysyl oxidase is associated with endothelial dysfunction, whereas upregulation of 
this enzyme can induce neointimal thickening in atherosclerosis (34).  Multimerin-2 is an EC-
specific ECM protein that also interacts with fibronectin and is required for remodeling of 
secreted fibronectin into fibrils (35).  Intriguingly, both multimerin-2 and dystroglycan-1 interact 
with the pro-angiogenic lectin CD93 in ECs (35, 36), suggesting that the potential for co-
trafficking and co-complex formation.  Finally, phospholipid transfer protein (PLTP) is a 
regulator of cholesterol efflux from ECs through its role in HDL formation.  Increases in 
circulating PTLP are linked to atherogenesis (37), suggesting that disruption of the normal 
polarity of secretion in this way would lead to pathogenesis. 
 
In addition to proteins that mimicked the loss of basolateral polarity seen with fibronectin, we 
also observed a subset of proteins that showed re-routing in the reverse direction – i.e. which lost 
strong apical polarization (Fig. 3E).  Again, these were all conventionally-secreted ECM 
proteins.  We saw re-routing of both subunits of collagen I to the basolateral surface.  
Intriguingly, we also saw re-routing of reticulocalbin-3 – a negative regulator of collagen I 
production with links to cardiac fibrosis (38).  The fourth protein was ECM1 – a protein with an 
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organizing function for the basement lamina and another interacting partner of fibronectin (39).  
The rerouting of collagen I towards the basolateral surface in response to perturbation of 
fibronectin secretion implies the existence of cross-talk between those two intracellular sorting 
pathways and reactive regulation of the composition of the vascular matrix. 
 
DISCUSSION 
In an adult human, the endothelial cell (EC) surface is composed approximately of 10-60 trillion 
cells, weighs approximately 1kg, and covers a surface area of 1-7 m2 (40).  This makes the 
endothelium one of the largest secretory organs in the body, and yet we still know relatively little 
about the proteins that it secretes, or how this secretion is regulated.  ECs form the interface 
between to very distinct compartments – the circulation and the vascular matrix.  It is clear that 
polarized secretion allows for the correct proteins to be delivered to the correct destination; 
however, we currently know the destinations of only a handful of EC proteins.  Here we present 
the first polarized EC secretome and demonstrate marked differences in secretion at the two EC 
surfaces.  We show that conventionally secreted proteins are distributed between the apical and 
basolateral surfaces, with a strong enrichment for ECM components in the basolateral proteome.  
We find that secretion of extracellular vesicle cargoes is strongly polarized to the apical surface.  
 
It is clear that ECs have mechanisms to allow for the sorting of proteins to the correct 
compartment; however, our understanding of these mechanisms is extremely limited.  We 
examined one of these mechanisms – the role of liprin-α1 in the sorting of fibronectin to the 
basolateral surface.   Polarized sorting of fibronectin appears to be a distinct function of ECs (41) 
and liprin-α1 mediates sorting of a complex of soluble fibronectin and activated integrin α5ß1 to 
the basolateral face of ECs (32).  We used our platform to determine if other cargoes were sorted 
through this route and identified 4 additional proteins that depended on liprin-α1 for effective 
delivery to the basolateral compartment.  Interestingly, three of these are known to bind directly 
fibronectin, or to binding partners of fibronectin.  Fibronectin is known to be targeted to specific 
ECM contact sites at the basolateral surface (35).  Co-trafficking of these proteins through the 
liprin-α1 pathway would ensure their co-location at the EC/ECM interface.  These findings 
demonstrate the ability of this approach to dissect the mechanism of polarized protein sorting in 
 15
ECs.  The fact that the majority of EC proteins are not affected by liprin-α1 depletion tells us that 
there must be further, unknown mechanisms of polarized trafficking to be discovered.  
 
Going forward, our proteomic platform offers three advantages for the analysis of EC secretion.  
First, the improved barrier function allows the asymmetric distribution of proteins to be 
maintained for long periods after secretion, aiding analysis.  Second, the optimized medium 
formulation is essentially protein-free, which allows significant concentration of the medium 
prior to analysis, increasing the sensitivity of detection.  Third, our method allows for the 
derivation of deep, robust proteomes from small samples (c.a. 105 primary cells), allowing for 
the analysis of samples from specialized conditions and/or endothelial subtypes.  Important 
problems to address include the changes to the vascular ECM composition seen in various 
vascular diseases (42), which may involve dysregulation of polarized secretion.  This method is 
also amenable to the study of the differences in secretion between different vascular beds – and 
the consequent unique homeostatic and regenerative contributions that these different ECs make 
to their tissues.  In both cases, the small sample size required will allow for the study of rare or 
difficult to obtain samples. 
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FIGURE LEGENDS 
Fig. 1  Optimization of an endothelial monolayer.  A) HUVEC were grown in Transwell inserts 
for 24h to achieve confluence.  Medium was then removed and replaced with either complete 
EGM-2, or EGM-2 lacking various supplements, as indicated.  FITC-dextran was added to the 
top chamber and its passage across the monolayer was measured by fluorimetry of the medium 
from the bottom chamber after 24h.  Hydrocortisone, FGF-2 and IGF-1 were required for 
maximum barrier function, whereas serum increased permeability.  Data are means ± SEM 
(n≥3).  B) HUVEC were cultured in Transwell inserts as before and allowed to condition HIFA 
medium for 48h.  Medium from the apical (A) or basolateral (B) chambers was concentrated and 
the protein content was compared to unconditioned medium by SDS-PAGE and Coomassie 
staining.  Samples of the FGF and IGF-1 supplements where included for comparison.  Most of 
the protein in the conditioned medium derived from these supplements.  The FGF and IGF-1 
supplements were replaced with highly-purified recombinant proteins to make HIFA2, which 
contained no detectable protein content.  C) HUVEC were cultured to confluence in Transwell 
inserts and then transferred to fresh EGM-2 or HIFA2 for 24h.  Cells were then fixed and stained 
for the junctional proteins VE-cadherin (green) and ZO-1(red).  HUVEC in HIFA2 displayed 
more regular, linear cell-cell junctions.  Scale bar = 10μm.  D) HUVEC were grown to 
confluence in Transwell inserts and then transferred to HIFA2 medium.  Fatty acid free BSA 
(0.1μg/ml) was added to either the top or bottom chambers, or to both.  The concentration of 
BSA in both chambers after 24h was determined by SDS-PAGE and Coomassie staining.  The 
panel shows a representative gel and quantification by densitometry.  Less than 20% of the 
exogenous BSA crossed the monolayer in either direction over 24h.  Data are means ± SEM 
(n=3).   
Fig. 2  Proteomic analysis of polarized endothelial cell secretion.  A) The apical and basolateral 
EC proteomes were derived from three independent experiments.  The Venn diagram shows the 
total number of proteins detected in each case, and the overlap in identification between the three 
datasets.  B) To analyze the distribution of proteins between the apical and basolateral 
compartments, Log2 ratios (apical/basolateral) where plotted for 840 proteins detected in two or 
more experiments.  The majority of proteins were polarized to the apical surface.  C) Further 
analysis interrogated the trafficking routes of these proteins.  Conventional soluble secreted 
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proteins where identified from the VerSeDa as having no predicted transmembrane region and a 
SignalP score of >0.6.  Extracellular vesicle cargoes were obtained from the EVpedia database 
by matching against the top 500 predicted human EV proteins.  Conventional secretion was 
slightly biased towards the basolateral compartment, whereas EV proteins secretion was strongly 
biased towards the apical compartment.  ECM components were identified by interrogating the 
Matrisome project database.  These resembled the distribution of conventionally secreted 
proteins as a whole.  D) Two conventionally secreted proteins were selected as representative of 
basolateral (Tsp1) and apical (Ang2) cargoes.  The distribution between the apical and 
basolateral compartments predicted by TMT mass spectrometry was compared to quantification 
by ELISA.  In both cases, the proteomic data was closely aligned to the ELISA quantification.  
Data are means ± SEM (n=3). 
 
Fig. 3  Liprin-α1controls sorting of a subset of ECM proteins to the basolateral surface.  A) 
HUVEC were treated with siRNAs targeting liprin-α1 and the effectiveness of silencing was 
determined by western blotting after 48h.  All three siRNAs gave significant depletion of 
endogenous liprin-α1.  B) The effect of the two most effective liprin-α1 siRNAs on EC 
permeability was determined by measuring the passage of FITC-dextran across the monolayer.  
Neither siRNA had a significant effect on permeability.  Data are means ± SEM (n=3).  C) 
HUVEC were treated with siRNA targeting liprin-α1 and the polarized secretion of fibronectin 
was quantified by ELISA of conditioned medium.  Depletion of liprin-α1 had no effect on the 
apical secretion of fibronectin, but significantly inhibited the basolateral secretion.  Data are 
means ± SEM (n=4); * P<0.05.  D) HUVEC were treated with or without liprin-α1 siRNA and 
the apical and basolateral secreted proteomes were derived by TMT mass spectrometry.  The 
vast majority of proteins showed no difference in the polarity of their secretion.  A subset of 
proteins (red) showed a marked reduction in basolateral polarization.  Conversely, a subset 
showed a marked reduction in apical polarization (blue).   
 
TABLE LEGENDS 
Table 1 The table shows the five most apically and five most basolaterally polarized proteins 
from the proteomic analysis.  The most apical proteins corresponded to cargoes known to be 
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packaged into extracellular vesicles, whereas the most basolateral proteins were conventionally 
secreted ECM components.  The table shows the mean ratios ± SEM (n=3).   
Table 2  The table shows the identities of the proteins who markedly lose basolateral 
polarization on liprin-α1 depletion, in comparison to fibronectin.  Also shown are the proteins 
who markedly lose apical polarization on liprin-α1 depletion. 
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Basolateral 
 
Accession Description Ratio (A/B) SEM 
    
A8K7E0 Biglycan 0.424 0.033 
Q13201 Multimerin-1 0.433 0.039 
A0A024RAB6 Perlecan 0.438 0.026 
D3DQH8 Osteonectin 0.495 0.024 
A0A024R462 Fibronectin 1 0.498 0.047 
 
Apical 
 
Accession Description Ratio (A/B) SEM 
    
A0A0K0K1K4 Proteasome subunit alpha 6.522 0.816 
P62701 40S ribosomal protein S4 6.146 1.189 
Q8WVX7 Ribosomal protein S19 5.341 0.731 
P25788 Proteasome subunit alpha type-3 5.090 0.683 
P62195 26S protease regulatory subunit 8 4.388 0.635 
 
Table 2 
 
 
 
 
 
Basolateral > Apical 
  control siLiprin-α1 
Accession Description Ratio (A/B) Ratio (A/B) 
    
A0A024R2W4 Dystroglycan-1 0.152 0.450 
D0PNI2 Lysyl oxidase 0.208 0.693 
B3KUE5 Phospholipase transfer protein 0.246 0.981 
Q9H8L6 Multimerin-2 0.365 0.876 
A0A024R462 Fibronectin 1 0.349 0.434 
 
 
Apical > Basolateral 
  control siLiprin-α1 
Accession Description Ratio (A/B) Ratio (A/B) 
    
A0A140VJI7 ECM1 1.353 0.487 
A0A0S2Z3H5 Collagen I A2 3.109 0.659 
Q96D15 Reticulocalbin-3 3.662 1.041 
P02452 Collagen I A1 10.87 0.540 
 
SUPPLEMENTAL TABLE LEGEND 
 
 
Supplemental Table S1A  The Table shows the abundance ratios (apical/basolateral) for 
proteomic analysis of polarized endothelial cell secretion from three independent experiments.   
 
 
Supplemental Table S1B  The Table shows the abundance ratios (apical/basolateral) for 
proteomic analysis of polarized secretion in endothelial cells treated with liprin-1siRNA. Data 
are shown from three independent experiments, together with data for endothelial cells treated in 
parallel with an siRNA control.   
 
